ID: ALA2094100

Max Phase: Preclinical

Molecular Formula: C12H17N5O5

Molecular Weight: 311.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)c1nc2c(O)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C12H17N5O5/c1-16(2)12-15-6-9(13-4-14-10(6)21)17(12)11-8(20)7(19)5(3-18)22-11/h4-5,7-8,11,18-20H,3H2,1-2H3,(H,13,14,21)/t5-,7-,8-,11-/m1/s1

Standard InChI Key:  YNXIJOYYBJOOJH-IOSLPCCCSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 311.30Molecular Weight (Monoisotopic): 311.1230AlogP: -1.79#Rotatable Bonds: 3
Polar Surface Area: 136.99Molecular Species: NEUTRALHBA: 10HBD: 4
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.59CX Basic pKa: 0.16CX LogP: -0.77CX LogD: -0.77
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.52Np Likeness Score: 0.63

References

1. Lin TS, Cheng JC, Ishiguro K, Sartorelli AC..  (1985)  Purine and 8-substituted purine arabinofuranosyl and ribofuranosyl nucleoside derivatives as potential inducers of the differentiation of the Friend erythroleukemia.,  28  (10): [PMID:3862866] [10.1021/jm00148a018]

Source